期刊文献+

IL-10、IFN-γ在外阴阴道念珠菌病患者发病中的作用 被引量:7

Effection of Interleukin-10 and Interferon-gamma with pathogenesis of Vulvovaginal Candidiasis Patients
下载PDF
导出
摘要 目的检测白细胞介素-10(IL-10)、干扰素-γ(IFN-γ)在正常女性、外阴阴道念珠菌病及复发性外阴阴道念珠菌病阴道分泌物中的表达水平。探讨细胞因子IL-10和IFN-γ的表达水平与外阴阴道念珠菌病发病的关系。方法ELISA法检测初发组和复发组念珠菌性阴道炎的妇女阴道分泌物中IL-10、IFN-γ的表达水平,以健康体检妇女为对照组。结果初发和复发念珠菌性阴道炎的阴道分泌物中IL-10的表达水平均显著高于对照组,复发组较初发组的表达水平也有显著性差异(P<0.05);初发和复发念珠菌性阴道炎的阴道分泌物中IFN-γ的表达水平无显著性差异(P>0.05),但均高于健康对照组(P<0.05)。结论Th1型和Th2型细胞因子的表达异常可能与念珠菌性阴道炎发病和复发有关。 Objective To detect the level of interleukin-10(IL-10) and interferon-gamma(IFN -γ) in the vaginal secretions of vulvovaginal eandidiasis patients and to investigate their relationship with the pathogenesis of vulvovaginal eandidiasis. Methods The expression level of the IL-10 and IFN-γ in the vaginal secretions from vulvovaginal eandidiasis patients was detected by ELISA and compared with that from normal controls. Results The level of IL-10 and IFN-γ in both incipient and relapse groups of vulvovaginal eandidiasis were significantly higher than that in control group (both P〈0. 05) ; the level of IL-10 in relapse group was higher than in incipient group, There was no significant difference of IFN-γlevel between incipient and relapse group ( P 〉 0. 05) . Conclusion The abnormal expression of the Th1 and Th2 cytokines might participate in the pathogenesis and the recrudescence of vulvovaginal candidiasis.
出处 《四川解剖学杂志》 2008年第2期25-27,共3页 Sichuan Journal of Anatomy
关键词 白细胞介素-10 干扰素-Γ 外阴阴道念珠菌病 Interleukin-10 Interferon- gamma Vulvovaginal Candidiasis
  • 相关文献

参考文献10

  • 1Sobel JD, Faro S, Force RW, et al . Vulvovaginal candidiasis : epidemiologic diagnostic, and therapeutic considerations. Am J Obstet Gynecol , 1998 , 178 : 203-211.
  • 2刘菲,廖秦平.外阴阴道念珠菌病致病机制和免疫防御机制的研究进展[J].中国妇产科临床杂志,2006,7(3):227-228. 被引量:21
  • 3Sobel JD. Pathogenesis and treatment of recurrent vulvovaginal candidiasis. Clin Infect Dis , 1992 , 14 : S148-153.
  • 4Wozniak KL, Palmer G, Kutner R, et al. Immunotherapeutic approaches to enhance protective immunity against Candida vaginitis. Med Mycol , 2005 , 43(7):589-601.
  • 5Fidel PL Jr, Ginsburg KA, Cutright JL, et al. Vaginal-associated immunity in women with recurrent vulvovaginal candidiasis: evidence for vaginal Th1-type responses following intravaginal challenge with Candida antigen. J Infect Dis. 1997,176 (3) : 728-739.
  • 6Carvalho LP, Bacellar O, Neves N, et al. Downregulation of IFN-Tproduction in patients with recurrent vaginal candidiasis. J Allergy Clin Immunol , 2002 , 109 : 102-105.
  • 7Cassone A, De Bernardis F, Santoni G. Anticandidal immunity and vaginitis: novel opportunities for immune intervention. Infect Immun, 2007 , 75(10):4675-4686.
  • 8Mohanty S, Xess I, Hasan F, et al . Prevalence & susceptibility to fluconazole of Candida species causing vulvovaginitis . Indian J Med Res,2007,126(3) : 216-219.
  • 9Fidel PL. Immune Regulation and it s role in the pathogenesis of candida vaginitis[J]. Curr Infect Dis Rep , 2003 , 5 (6) : 488-493.
  • 10Nawrot V , Grzybek HK, Zielska V , et al . The study of cell- mediated immune response in recurrent Vulvo-vaginal candidiasis.FEMs Immunol Med Microbiol ,2000 ,29 (2) :89-94.

二级参考文献15

  • 1[1]Sobel JD,Faro S,Force RW,et al.Vulvovaginal candidiasis:epidemiologic diagnostic,and therapeutic considerations.Am J Obstet Gynecol,1998,178:203-211.
  • 2[2]Sobel JD.Pathogenesis and treatment of recurrent vulvovaginal candidiasis.Clin Infect Dis,1992,14:S148-153.
  • 3[3]Abu-Eltecn KH.Increased incidence of vulvovaginal candidiasis caused by candida glabrata in Jordan.Jpn J Infect Dis,2001,54:103-107.
  • 4[4]Rocha CRC,Schroppel K,Harcus D,et al.Signaling through adenylyl cyclase is essential for hyphal growth and virulence in the pathogentic fungns candida albicans.Mol cell boil,2001,12:3631-3643.
  • 5[7]Schaller M,Bein M,Korting HC,et al.The secreted aspartyl proteinases Sap1 and Sap2 cause tissue darage in an in vitro model of vaginal candidiasis based on reconsitituted human vaginal epithelium.Infect Immun,2003,71:3227-3234.
  • 6[8]Fidel PL Jr,Sober JD.The role of cell-mediated immunity in candidiasis.Trands Microbiol,1994,2:202-206.
  • 7[9]Wormley FL Jr,Cutright J,Fldel PL Jr.Multiple experimental designs to evaluate the role of T cell-mediated immunity against experimental vaginal candida albicans infection.Med Mycol,2003,41:401-409.
  • 8[10]Carvalho LP,Bacellar O,Neves N,et al.Downregulatiun of IFN-γproduction in patients with recurrent vaginal candidiasis.J Allergy Clin Immunol,2002,109:102-105.
  • 9[11]Pellis V,De Seta F,Crovella S,et al.Mannose-binding lectin and C3 act as recognition molecules for infectious agents in the vagina.Clin Exp Immunol,2005,139:120-126.
  • 10[12]Neth O,Jack DL,Dodds AW,et al.Mannose-binding lectin binds to a range of clinically relevant microorganisms and promotes complement diposition.Infect immune,2000,68:688-693.

共引文献20

同被引文献51

引证文献7

二级引证文献47

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部